| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/25/2009 | EP1015445B1 Antimicrobial quinolones, their compositions and uses |
| 02/25/2009 | CN101374841A Spiro imidazole derivatives as PPAR modulators |
| 02/25/2009 | CN101374840A 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors |
| 02/25/2009 | CN101374839A Azaindoles useful as inhibitors of janus kinases |
| 02/25/2009 | CN101374838A 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors |
| 02/25/2009 | CN101374837A Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 02/25/2009 | CN101374836A Muscarinic agonists and methods of use thereof |
| 02/25/2009 | CN101374831A Tetrahydropyrane antibiotics |
| 02/25/2009 | CN101374828A Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
| 02/25/2009 | CN101374816A Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds |
| 02/25/2009 | CN101374519A Modulators of muscarinic receptors |
| 02/24/2009 | US7495111 Compounds useful as serotonin inhibitors and 5-HT1A agonists and antagonists |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495101 Reacting 4-methyl-5-alkoxy-oxazole with substituted dihydro-(1,3)-dioxepin compound, in absence of solvent and catalyst to give product mixture consisting of Diels-Alder adducts; distillation; hydrolysis; deblocking, deprotecting; deacylation |
| 02/24/2009 | US7495096 Processes for the production of chinazoline alkaloids |
| 02/24/2009 | US7495014 Gyrase inhibitors and uses thereof |
| 02/24/2009 | US7495009 Imidazopyridine derivatives as melancortin receptor agonists |
| 02/24/2009 | US7495007 Spiroindolinone derivatives |
| 02/24/2009 | US7495000 Variolin derivatives and their use as antitumor agents |
| 02/24/2009 | US7494721 Light-emitting device, condensed polycyclic compound used therein and method for producing same |
| 02/19/2009 | WO2009023253A2 IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
| 02/19/2009 | WO2009023179A2 Nitrogen containing bicyclic chemical entities for treating viral infections |
| 02/19/2009 | WO2009022961A1 Pyrrolopyridine derivatives and their use as bace inhibitors |
| 02/19/2009 | WO2009022740A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as the active ingredient |
| 02/19/2009 | WO2009022104A1 Fascaplysin derivatives and their use in the treatment of cancer |
| 02/19/2009 | WO2009021990A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | WO2009021961A1 Pyrazoloquinoline and pyrazolonaphthyridine derivatives as gaba alpha ligands |
| 02/19/2009 | WO2009021957A2 Tricyclic heterocyclic compounds as gaba a modulators |
| 02/19/2009 | WO2008157404A3 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 02/19/2009 | WO2008155745A3 New process for the manufacture of 1h-imidazo[4,5-c]-quinoline ring systems |
| 02/19/2009 | WO2008130600A3 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| 02/19/2009 | WO2008121506A3 Renin inhibitors |
| 02/19/2009 | WO2008087557A3 An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride |
| 02/19/2009 | WO2007095389A3 Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs |
| 02/19/2009 | US20090048444 Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives |
| 02/19/2009 | US20090048285 Pyrrolopyridines Useful in the Treatment of Inflammation |
| 02/19/2009 | US20090048277 N-methylamide of 7-[6-(2,6-dichlorophenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino]-2,3-dihydrobenzo[1,4]dioxin-2-carboxylic acid; antiproliferative agents; anticarcinogenic agents |
| 02/19/2009 | US20090048276 Inhibitors of Fatty Acid Synthase (Fas) |
| 02/19/2009 | US20090048250 protein kinase inhibitors such as 6-[4-(5-Cyclopropyl-2H-pyrazol-3-ylamino)-quinazolin-2-ylamino]-1,2-dihydro-indazol-3-one, used for treating diabetes, infections, inflammatory, allergic, autoimmune, proliferative, viral and Alzheimer's diseases, or immunodeficiency, cardiovascular and bone disorders |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048246 Compounds, compositions and methods for reducing lipid levels |
| 02/19/2009 | US20090048245 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048230 Compounds and compositions useful as cathepsin s inhibitors |
| 02/19/2009 | US20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090047246 Novel inhibitors of hepatitis c virus replication |
| 02/19/2009 | US20090044863 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof |
| 02/19/2009 | CA2696041A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient |
| 02/19/2009 | CA2695989A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| 02/19/2009 | CA2695456A1 3' substituted compounds having 5-ht6 receptor affinity |
| 02/19/2009 | CA2695251A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | CA2687332A1 Pyrrolopyridine derivatives and their use as bace inhibitors |
| 02/19/2009 | CA2681267A1 Anti-angiogenic agents and methods of use |
| 02/18/2009 | EP2024366A2 Monocyclic heteroaryl compounds |
| 02/18/2009 | EP2024365A2 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 02/18/2009 | EP2024361A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof |
| 02/18/2009 | EP2024358A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/18/2009 | EP2024356A1 Bicyclic derivatives as cetp inhibitors |
| 02/18/2009 | EP2024325A1 2,5-di(methoxyanilino)terephthalic acid polymorphs and quinacridones realized therefrom |
| 02/18/2009 | EP2023933A2 Acetylenic heteroaryl compounds |
| 02/18/2009 | EP1902054B1 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof and the therapeutic application of the same |
| 02/18/2009 | EP1899333B1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 02/18/2009 | EP1675852B1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 02/18/2009 | EP1575952B1 Synthesis of heteroaryl acetamides |
| 02/18/2009 | EP1463563B1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1392298B1 Fused heterocyclic compounds |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370810A Diaza-spiro-[4, 5]-decanes useful as pesticides |
| 02/18/2009 | CN101370809A Novel diazabicycloalkane derivatives and their medical use |
| 02/18/2009 | CN101370808A Tetrabenzodiazadiketoperylene colourants in ir-reflective coatings and plastics |
| 02/18/2009 | CN101370807A Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via GABA receptors |
| 02/18/2009 | CN101370776A 5-(arylsulfonyl)-pyrazolopiperidines |
| 02/18/2009 | CN101370497A Combination therapy with PARP inhibitors |
| 02/18/2009 | CN101369633A Pyran derivative |
| 02/18/2009 | CN101367823A Method for separating citrate, evodiamine and rutaecarpine from evodia rutaecarpa |
| 02/18/2009 | CN101367802A Beta-kabarin alkaloids in quassia wood, preparation method and application thereof |
| 02/18/2009 | CN101367801A Preparation method for pyrrol-hexahydric N heterocycle hydroxyl morpholine derivants, and medical uses thereof |
| 02/18/2009 | CN101367799A Matrine salviol acid B complex salt and kuh-seng native salviol acid B complex salt, preparation method and application thereof |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/17/2009 | US7491831 PPAR active compounds |
| 02/17/2009 | US7491743 Inhibitors of cellular necrosis |
| 02/17/2009 | US7491737 Heterarylpiperidine modulators of chemokine receptor activity |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491729 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | US7491716 Glycogen synthase kinase-3 inhibitors such as [1-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-6,7-dihydro-6H-[1,4]diazepino[6,7,1-hi]indol-6-yl]-[morpholin-4-yl]methylenecyanamide, used for treating diabetes, Alzheimer's disease and for stimulating bone deposition in mammals |
| 02/17/2009 | US7491714 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 02/17/2009 | US7491692 admixing a supplement selected from the therapeutically active agents for facilitating axon growth and a flowable carrier component capable of forming a matrix in vivo at a nerve lesion site and the active agent is releasable from the matrix |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/13/2009 | CA2597193A1 Compounds and uses |
| 02/12/2009 | WO2009020589A1 Silicon derivatives as histone deacetylase inhibitors |
| 02/12/2009 | WO2009020470A2 Cgrp receptor antagonists |
| 02/12/2009 | WO2009019553A2 Imidazopyridinones |
| 02/12/2009 | WO2009019506A1 Heterocyclyc sulfonamides having edg-1 antagonistic activity |